Market News

Welch Group Has Upped By $1.46 Million Its The Southern Company (SO) Holding; Boston Scientific (BSX) Had 26 Analysts Last Week

Boston Scientific Corporation (NYSE:BSX) Logo

Among 32 analysts covering Boston Scientific Corporation (NYSE:BSX), 26 have Buy rating, 0 Sell and 6 Hold. Therefore 81% are positive. Boston Scientific Corporation had 99 analyst reports since July 27, 2015 according to SRatingsIntel. As per Thursday, August 31, the company rating was maintained by Needham. The firm has “Buy” rating by Stifel Nicolaus given on Wednesday, April 25. The stock of Boston Scientific Corporation (NYSE:BSX) has “Hold” rating given on Monday, May 1 by Oppenheimer. BTIG Research maintained Boston Scientific Corporation (NYSE:BSX) on Sunday, September 6 with “Buy” rating. Raymond James maintained it with “Strong Buy” rating and $34 target in Thursday, April 26 report. On Thursday, November 30 the stock rating was upgraded by BTIG Research to “Buy”. BMO Capital Markets maintained the stock with “Buy” rating in Wednesday, November 29 report. Needham maintained the shares of BSX in report on Wednesday, October 28 with “Buy” rating. The stock has “Buy” rating by Needham on Thursday, June 22. Jefferies maintained it with “Hold” rating and $28.0 target in Friday, October 6 report. See Boston Scientific Corporation (NYSE:BSX) latest ratings:

01/05/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $32 New Target: $34 Maintain
25/04/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $33.0000 Maintain
25/04/2018 Broker: Jefferies Rating: Hold New Target: $31.0000 Maintain
26/04/2018 Broker: Raymond James Old Rating: Strong Buy New Rating: Strong Buy Old Target: $32 New Target: $34 Maintain
26/04/2018 Broker: Leerink Swann Old Rating: Outperform New Rating: Outperform Old Target: $32 New Target: $33 Maintain
26/04/2018 Broker: JP Morgan Old Rating: Overweight New Rating: Overweight Old Target: $31 New Target: $32 Maintain
25/04/2018 Broker: Needham Rating: Buy New Target: $36.0000 Maintain
05/04/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $30 New Target: $34 Maintain
19/03/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $30 New Target: $33 Maintain
23/02/2018 Broker: Piper Jaffray Rating: Buy New Target: $31.0 Initiate

Welch Group Llc increased The Southern Company (SO) stake by 8.71% reported in 2017Q4 SEC filing. Welch Group Llc acquired 30,516 shares as The Southern Company (SO)’s stock declined 8.19%. The Welch Group Llc holds 380,951 shares with $18.32M value, up from 350,435 last quarter. The Southern Company now has $44.97B valuation. The stock increased 0.45% or $0.2 during the last trading session, reaching $44.45. About 88,179 shares traded. The Southern Company (NYSE:SO) has declined 11.47% since May 25, 2017 and is downtrending. It has underperformed by 23.02% the S&P500.

Investors sentiment increased to 1.1 in Q4 2017. Its up 0.10, from 1 in 2017Q3. It is positive, as 56 investors sold SO shares while 329 reduced holdings. 75 funds opened positions while 350 raised stakes. 548.17 million shares or 4.36% more from 525.28 million shares in 2017Q3 were reported. Woodley Farra Manion Management, Indiana-based fund reported 76,454 shares. Marathon Trading Inv Management Llc has invested 0.02% of its portfolio in The Southern Company (NYSE:SO). Moreover, Klingenstein Fields & Limited Liability Com has 0.02% invested in The Southern Company (NYSE:SO). Lodestar Invest Counsel Ltd Liability Company Il reported 15,184 shares. Verity Asset Mngmt accumulated 5,807 shares. Wolverine Asset Management Ltd has 6,545 shares. Ntv Asset Mngmt Llc has 27,477 shares for 0.37% of their portfolio. 10,921 were accumulated by Comerica Secs. Toth Advisory Corporation holds 575 shares or 0.01% of its portfolio. First Commonwealth Fin Pa stated it has 0.21% in The Southern Company (NYSE:SO). Arrowgrass Capital Partners (Us) Lp invested 0.02% in The Southern Company (NYSE:SO). First Heartland Consultants has 5,745 shares for 0.08% of their portfolio. Confluence Inv Ltd reported 2.05 million shares. Mogy Joel R Counsel Incorporated reported 35,591 shares. Amica Pension Fund Board Of Trustees reported 51,552 shares.

More recent The Southern Company (NYSE:SO) news were published by: Seekingalpha.com which released: “Southern Company Is Offering An Almost 8-Year High Dividend Yield” on May 17, 2018. Also Seekingalpha.com published the news titled: “Southern Power to sell 33% stake in solar portfolio for $1.175B” on May 23, 2018. Streetinsider.com‘s news article titled: “Southern Co. (SO) Reports Sale of Certain Florida Assets to NextEra Energy (NEE) for About $6.48 Billion” with publication date: May 21, 2018 was also an interesting one.

Among 20 analysts covering The Southern Company (NYSE:SO), 5 have Buy rating, 5 Sell and 10 Hold. Therefore 25% are positive. The Southern Company had 78 analyst reports since July 21, 2015 according to SRatingsIntel. On Monday, April 16 the stock rating was maintained by Morgan Stanley with “Underweight”. The firm earned “Hold” rating on Wednesday, December 6 by SunTrust. Morgan Stanley maintained the shares of SO in report on Tuesday, February 13 with “Underweight” rating. The rating was maintained by SunTrust with “Hold” on Monday, January 22. The stock of The Southern Company (NYSE:SO) earned “Buy” rating by Mizuho on Friday, December 8. As per Thursday, April 13, the company rating was maintained by Jefferies. The firm earned “Hold” rating on Friday, March 31 by BMO Capital Markets. The firm has “Hold” rating given on Friday, March 3 by Argus Research. On Monday, May 7 the stock rating was maintained by Credit Suisse with “Neutral”. The rating was maintained by SunTrust with “Hold” on Monday, April 23.

Boston Scientific Corporation develops, makes, and markets medical devices for use in various interventional medical specialties worldwide. The company has market cap of $41.94 billion. It operates through three divisions: Cardiovascular, Rhythm Management, and MedSurg. It has a 400 P/E ratio. The firm offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems.

Since December 29, 2017, it had 0 buys, and 18 sales for $9.29 million activity. $136,125 worth of Boston Scientific Corporation (NYSE:BSX) was sold by Pierce David A. On Monday, March 5 Sorenson John Bradley sold $53,496 worth of Boston Scientific Corporation (NYSE:BSX) or 1,950 shares. Shares for $603,368 were sold by Thepaut Eric Francis Yves. Ballinger Kevin J. had sold 42,803 shares worth $1.21 million on Wednesday, March 14. Fitzgerald Joseph Michael had sold 85,227 shares worth $2.26M on Wednesday, February 7. $399,865 worth of Boston Scientific Corporation (NYSE:BSX) was sold by Phalen Michael P.. On Thursday, May 10 the insider Butcher Arthur C sold $225,413.

Investors sentiment increased to 1.34 in 2017 Q4. Its up 0.30, from 1.04 in 2017Q3. It is positive, as 36 investors sold Boston Scientific Corporation shares while 158 reduced holdings. 86 funds opened positions while 174 raised stakes. 1.18 billion shares or 2.38% less from 1.21 billion shares in 2017Q3 were reported. Price Michael F owns 284,200 shares. 149,752 are held by Sio Mngmt Ltd Liability. The United Kingdom-based Gulf Financial Bank (Uk) Ltd has invested 0.14% in Boston Scientific Corporation (NYSE:BSX). Focused Wealth Mngmt reported 100 shares. Raymond James holds 620,995 shares or 0.03% of its portfolio. Qs Investors Ltd Limited Liability Company accumulated 0.01% or 57,612 shares. Comerica Securities Incorporated holds 0.04% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 13,719 shares. Warren Averett Asset Management Limited Liability Com owns 14,412 shares for 0.05% of their portfolio. Jump Trading, a Illinois-based fund reported 10,435 shares. Quantres Asset Ltd reported 26,100 shares. Koch Indus owns 19,240 shares for 0.07% of their portfolio. Fjarde Ap holds 0.14% or 382,272 shares in its portfolio. Old Mutual Customised Solutions (Proprietary) Limited, a South Africa-based fund reported 18,397 shares. Jane Street Gp Limited Liability Company owns 64,367 shares. Washington Commercial Bank holds 899 shares or 0% of its portfolio.

More news for Boston Scientific Corporation (NYSE:BSX) were recently published by: Streetinsider.com, which released: “JANA Shows New Stakes in Apple (AAPL), Boston Scientific (BSX), Dropbox (DBX), iQIYI (IQ) (more..) -13F” on May 15, 2018. Forbes.com‘s article titled: “A Quick Snapshot Of Boston Scientific’s Rhythm Management & Neuro Segment” and published on May 16, 2018 is yet another important article.

Boston Scientific Corporation (NYSE:BSX) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *